Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
0.3100
0.00 (0.00%)
At close: Feb 13, 2026
HKG:8189 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 52.27 | 25.4 | 5.93 | 6.86 | 26.44 | 13.53 |
Trading Asset Securities | - | - | - | 0.35 | 1 | 22 |
Cash & Short-Term Investments | 186.13 | 25.4 | 5.93 | 7.21 | 27.44 | 35.53 |
Cash Growth | 100.72% | 328.02% | -17.68% | -73.73% | -22.78% | 46.54% |
Accounts Receivable | 34.22 | 10.82 | 8.78 | 31.87 | 32.08 | 43.89 |
Other Receivables | 12.75 | 3.49 | 9.39 | 6.55 | 6.85 | 8.18 |
Receivables | 46.97 | 14.31 | 18.16 | 45.11 | 42.87 | 58.97 |
Inventory | 83.99 | 75.31 | 90.46 | 74 | 75.22 | 91.64 |
Other Current Assets | -0 | 118.98 | 75.79 | 66.75 | 63.21 | 74.03 |
Total Current Assets | 317.08 | 233.99 | 190.34 | 193.07 | 208.75 | 260.17 |
Property, Plant & Equipment | 97.9 | 98.35 | 112.94 | 132.05 | 138.81 | 126.34 |
Long-Term Investments | - | - | - | - | - | 3.95 |
Goodwill | - | - | - | 5.53 | - | 0.42 |
Other Intangible Assets | - | - | - | 6.55 | 0.04 | 2.04 |
Other Long-Term Assets | 0.18 | 0.18 | - | - | - | - |
Total Assets | 415.16 | 332.53 | 303.28 | 337.2 | 347.6 | 392.92 |
Accounts Payable | 33.08 | 8.93 | 16.11 | 20.72 | 29.53 | 43.77 |
Accrued Expenses | 7.11 | 9.24 | 5.37 | 3.41 | 4.2 | 6.25 |
Short-Term Debt | - | 42.84 | 29.91 | 19.39 | 7 | 9 |
Current Portion of Long-Term Debt | 83.83 | 94.04 | 34.06 | 44 | 34.4 | 0.4 |
Current Portion of Leases | 3.2 | 1.56 | 1.5 | 3.98 | 3.73 | 1.79 |
Current Income Taxes Payable | 0.92 | - | - | 3.13 | 1.48 | 0.08 |
Current Unearned Revenue | 84.74 | 77.75 | 86.53 | 73.56 | 67.71 | 78.97 |
Other Current Liabilities | 74.49 | 44.7 | 43.37 | 50.05 | 43.96 | 54.07 |
Total Current Liabilities | 287.37 | 279.07 | 216.84 | 218.25 | 192.02 | 194.32 |
Long-Term Debt | 14.87 | 14.87 | 9.92 | - | 6 | 6.4 |
Long-Term Leases | 10.68 | 8.81 | 10.38 | 35.23 | 39.21 | 37.06 |
Long-Term Deferred Tax Liabilities | 1.34 | 1.34 | 1.56 | 2.56 | - | - |
Total Liabilities | 314.26 | 304.09 | 238.7 | 256.05 | 237.24 | 237.77 |
Common Stock | 213.39 | 189.45 | 189.45 | 189.45 | 189.45 | 189.45 |
Additional Paid-In Capital | 332.27 | 275.32 | 275.32 | 275.32 | 275.32 | 275.32 |
Retained Earnings | -432.2 | -425.78 | -397.98 | -377.82 | -347.15 | -304.89 |
Comprehensive Income & Other | -16.84 | -16.84 | -16.84 | -16.84 | -16.84 | -16.84 |
Total Common Equity | 96.62 | 22.15 | 49.95 | 70.11 | 100.78 | 143.04 |
Minority Interest | 4.29 | 6.29 | 14.63 | 11.04 | 9.58 | 12.11 |
Shareholders' Equity | 100.91 | 28.44 | 64.58 | 81.15 | 110.36 | 155.14 |
Total Liabilities & Equity | 415.16 | 332.53 | 303.28 | 337.2 | 347.6 | 392.92 |
Total Debt | 112.58 | 162.12 | 85.76 | 102.61 | 90.34 | 54.65 |
Net Cash (Debt) | 73.55 | -136.72 | -79.83 | -95.4 | -62.9 | -19.12 |
Net Cash Per Share | 0.04 | -0.07 | -0.04 | -0.05 | -0.03 | -0.01 |
Filing Date Shares Outstanding | 2,134 | 1,895 | 1,895 | 1,895 | 1,895 | 1,895 |
Total Common Shares Outstanding | 2,134 | 1,895 | 1,895 | 1,895 | 1,895 | 1,895 |
Working Capital | 29.71 | -45.07 | -26.5 | -25.17 | 16.72 | 65.86 |
Book Value Per Share | 0.05 | 0.01 | 0.03 | 0.04 | 0.05 | 0.08 |
Tangible Book Value | 96.62 | 22.15 | 49.95 | 58.04 | 100.74 | 140.58 |
Tangible Book Value Per Share | 0.05 | 0.01 | 0.03 | 0.03 | 0.05 | 0.07 |
Buildings | - | 92.25 | 91.53 | 90.38 | 75.49 | 68.09 |
Machinery | - | 86.31 | 96.06 | 95.78 | 89.39 | 85.81 |
Construction In Progress | - | - | 1.07 | 0.09 | 13.21 | 1.81 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.